ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000256458.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.041350567	Resistant
ENSG00000256458.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.009132155	Sensitive